2005
DOI: 10.1373/clinchem.2005.052746
|View full text |Cite
|
Sign up to set email alerts
|

Drug Testing in Blood: Validated Negative-Ion Chemical Ionization Gas Chromatographic–Mass Spectrometric Assay for Enantioselective Measurement of the Designer Drugs MDEA, MDMA, and MDA and Its Application to Samples from a Controlled Study with MDMA

Abstract: Background:The enantiomers of the designer drugs 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA), and 3,4-methylenedioxyethylamphetamine (MDEA) differ in their pharmacologic and toxicologic potency. The aim of this study was to develop an assay for measuring these enantiomers in small plasma volumes and to analyze samples from a controlled study with MDMA. Methods: The analytes were extracted from <0.2 mL of plasma by mixed-mode solid-phase extraction. After derivatization with S-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

6
55
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 50 publications
(61 citation statements)
references
References 37 publications
6
55
0
Order By: Relevance
“…The separation of the MDA enantiomers was comparable with that described by Peters et al (2005). The mass fragmentograms shown in Fig.…”
Section: Resultssupporting
confidence: 79%
See 4 more Smart Citations
“…The separation of the MDA enantiomers was comparable with that described by Peters et al (2005). The mass fragmentograms shown in Fig.…”
Section: Resultssupporting
confidence: 79%
“…2, B and C, purity check of the isolated enantiomers by GC-MS indicated high optical purities of S-MDMA-HCl (97%) and R-MDMA-HCl (98%), respectively. The elution order was confirmed according to (Peters et al, 2005). The yield was approximately 60% or 12 mg/enantiomer.…”
Section: Resultsmentioning
confidence: 96%
See 3 more Smart Citations